The blood pressure measurement-revisited

American Heart Journal

Volumn 152, Issue 3, 2006, Pages 417-419

  Safar, Michel E ^a   Smulyan, Harold ^b  

^a HÔTEL DIEU   (France)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; NITRIC ACID DERIVATIVE;

ANEMIA; ANTIHYPERTENSIVE THERAPY; AORTA VALVE REGURGITATION; ARTERIAL PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIA; MANOMETER; MECHANICAL STRESS; OSCILLOMETRY; PATIENT CARE; PRIORITY JOURNAL; PULSE PRESSURE; SHOCK; SPHYGMOMANOMETER; STETHOSCOPE; SYSTOLIC BLOOD PRESSURE; THYROTOXICOSIS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; HUMANS; HYPERTENSION; RISK FACTORS; SPHYGMOMANOMETERS;

EID: 33747171507     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.03.016     Document Type: Editorial

References (17)

1. American National Standard for Electronic or Automated Sphygmomanometers. ANSI/AAMI SP10-1992 (1993), Association for the Advancement of Medical Instrumentation, Arlington (VA) 12
2. Nichols W.W., and O'Rourke M. Chapter 9-contours of pressure and flow waves in arteries. McDonald's blood flow in arteries. Theoretical, experimental and clinical principles. 5th Ed. (2005), Arnold E, London 166-191
3. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
4. Devereux R.B., Dalhof B., Gerdts E., et al. Regression of left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial. Circulation 110 (2004) 1456-1462
5. Morgan T., Lauri J., Bertram D., et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 17 (2004) 118-123
6. Asmar R.G., London G.M., O'Rourke M.E., et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 38 (2001) 922-926
7. Hirata K., Vlachopoulos C., Adji A., et al. Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": beyond blood pressure or beyond the brachial artery?. J Hypertens 23 (2005) 551-556
8. de Luca N., Asmar R.G., London G.M., et al. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 22 (2004) 1623-1630
9. Nakayama Y., Tsumura K., Yamashita N., et al. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation 101 (2000) 470-472
10. Nishijima T., Nakayama Y., Tsumura K., et al. Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens 14 (2001) 469-473
11. Safar M.E., Blacher J., Pannier B., et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 39 (2002) 735-738
12. O'Brien E., Waeber B., Parati G., et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 322 (2001) 531-536
13. van Montfrans G.A. Oscillometric blood pressure measurement: progress and problems. Blood Press Monit 6 (2001) 287-290
14. Baker P.D., Westenskow D.R., and Kuck K. Theoretical analysis of non-invasive oscillometric maximum amplitude algorithm for estimating mean blood pressure. Med Biol Eng Comput 35 (1997) 271-278
15. Benjamin E.J., Larson M.G., Keyes K.J., et al. clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 109 (2004) 613-619
16. Dahlof B., Sever P.S., Poulter N.R., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a Multicentre Randomised Controlled Trial. Lancet 366 (2005) 895-906
17. Williams B., Lacy P.S., Thorn S.M., et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation 113 (2006) 1213-1225